Full Name
BUYSE, Marc
Email
marc.buyse@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Refined By:
Date Issued:  [2000 TO 2009]
Date Issued:  2006

Results 1-6 of 6 (Search time: 0.006 seconds).

Issue DateTitleContributor(s)TypeCat.
12006Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trialBogaerts, J.; Cardoso, F.; BUYSE, Marc; Braga, S.; Loi, S.; Harrison, J. A.; Bines, J.; Mook, S.; Decker, N.; Ravdin, P.; Therasse, P.; Rutgers, E.; van't Veer, L. J.; Piccart, M.Journal ContributionA1
22006Alternative clinical end points in rectal cancer—are we getting closer?Glynne-Jones, R; Mawdsley, S; Pearce, T; BUYSE, MarcJournal ContributionA1
32006Analysis of oxaliplatin reintroduction in patients with advanced colorectal cancer (CRC) treated with FOLFOX4 or FOLFOX7 in the optimox studyBUYSE, Marc; Quinaux, E; CORTINAS ABRAHANTES, Jose; Tournigand, C; Cervantes, A; Figer, A; André, Thierry; Tabah-Fisch, I; De Gramont, AJournal ContributionM
42006Current issues in adjuvant treatment of stage II colon cancerAndré, Thierry; Sargent, D; Tabernero, J; O'Connell, M; BUYSE, Marc; Sobrero, A; Misset, J.L.; Boni, C; de Gramont, AJournal ContributionA1
52006Surrogate threshold effect: An alternative measure for meta-analytic surrogate endpoint validationBURZYKOWSKI, Tomasz; BUYSE, MarcJournal ContributionA1
62006A unifying approach for surrogate marker validation based on Prentice's criteriaALONSO ABAD, Ariel; MOLENBERGHS, Geert; GEYS, Helena; BUYSE, Marc; VANGENEUGDEN, TonyJournal ContributionA1